Clinical Trial Update: Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program

View source ↗

Summary

Clinical trial NCT04557709, sponsored by MD Anderson Cancer Center, evaluating major complication rate in cancer patients with neutropenic fever for a potential…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Solid Tumor

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Status: WITHDRAWN